dipyridamole has been researched along with Telangiectasia, Hereditary Hemorrhagic in 1 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Telangiectasia, Hereditary Hemorrhagic: An autosomal dominant vascular anomaly characterized by telangiectases of the skin and mucous membranes and by recurrent gastrointestinal bleeding. This disorder is caused by mutations of a gene (on chromosome 9q3) which encodes endoglin, a membrane glycoprotein that binds TRANSFORMING GROWTH FACTOR BETA.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Koerper, MA | 1 |
| Addiego, JE | 1 |
| deLorimier, AA | 1 |
| Lipow, H | 1 |
| Price, D | 1 |
| Lubin, BH | 1 |
1 other study available for dipyridamole and Telangiectasia, Hereditary Hemorrhagic
| Article | Year |
|---|---|
Use of aspirin and dipyridamole in children with platelet trapping syndromes.
Topics: Aspirin; Blood Platelets; Dipyridamole; Female; Hemangioma; Humans; Infant; Male; Platelet Count; Te | 1983 |